PeploBio is a specialist CRO supporting pharmaceutical, biotech, and diagnostic partners in the development and clinical validation of immunological assays.
We combine scientific depth with operational agility to translate biomarker research into clinically validated tools. Our expertise spans immune monitoring, microclot quantification, assay development, and regulatory support — with a track record of delivering complex studies across FDA, IVDR, and UKCA frameworks.
Our Services:
- Microclot Detection & Quantification – Proprietary MicroCLOTS™ assay for measuring fibrin(ogen) amyloid microclots in Long COVID, ME/CFS, cardiovascular, and thromboinflammatory conditions
- Immune Monitoring – Custom flow cytometry and protein microarray panels for profiling immune dysfunction in oncology, infectious disease, and autoimmunity
- Assay Development & Validation – Analytical, usability, and clinical performance studies for RUO, LDT, and regulatory submissions
- Regulatory Strategy & Clinical Studies – Design and execution of studies for IVDR, FDA, and UKCA compliance.
Why PeploBio?
- Trusted partner to Translational Medicine teams, biotech innovators, and diagnostic manufacturers
- Expertise in both discovery-stage innovation and late-stage clinical deployment
- Agile team with global reach: based in London (UK), Cyprus (EU), and North Carolina (US)
Company Details
- Employees
- 7
- Founded
- -
- Address
- 40 Occam Road, Unit 26,united Kingdom
- Industry
- Biotechnology
- Website
- http://www.peplobio.com
- HQ
- Surrey Research Park, England
Peplobio Questions
Peplobio's website is http://www.peplobio.com
Peplobio's LinkedIn profile is https://uk.linkedin.com/company/peplobio
Peplobio has
7 employees.
View email and phone details for 7
employees at Peplobio.
Peplobio's industry is
Biotechnology
Peplobio's top competitors are
Incelldx,
Molecular Medical,
Ramona,
Cdi Labs,
Futura Medical,
Katalyst Diagnostics,
Luye Pharma Uk,
Healthbio,
N-Power Medicine, Inc.,
Merxin Ltd.
Peplobio's categories are Biotechnology
Peplobio's founding year is 2021
